Literature DB >> 1508198

Identification of DNA elements cooperatively activating proopiomelanocortin gene expression in the pituitary glands of transgenic mice.

B Liu1, G D Hammer, M Rubinstein, M Mortrud, M J Low.   

Abstract

The proopiomelanocortin (POMC) gene is highly expressed in adult mouse pituitary anterior lobe corticotrophs and intermediate lobe melanotrophs. To identify the DNA elements important for this tissue-specific expression, we analyzed a series of POMC reporter genes in transgenic mice. A DNA fragment containing rat POMC 5'-flanking sequences from -323 to -34 recapitulated both basal pituitary cell-specific and hormonally stimulated expression in adult mice when fused to a heterologous thymidine kinase promoter. Developmental onset of the reporter gene expression lagged by 1 day but otherwise closely paralleled the normal ontogeny of murine POMC gene expression, including corticotroph activation at embryonic day 14.5 (E14.5) followed by melanotroph activation at E15.5 to E16.5. AtT20 corticotroph nuclear protein extracts interacted with three specific regions of the functional POMC promoter in DNase I protection assays. The positions of these protected sites were -107 to -160 (site 1), -182 to -218 (site 2), and -249 to -281 (site 3). Individual deletions of these footprinted sites did not alter transgene expression; however, the simultaneous deletion of sites 2 and 3 prevented transgene expression in both corticotrophs and melanotrophs. Electrophoretic mobility shift and Southwestern (DNA-protein) assays demonstrated that multiple AtT20 nuclear proteins bound to these footprinted sites. We conclude that the sequences between -323 and -34 of the rat POMC gene promoter are both necessary and sufficient for correct spatial, temporal, and hormonally regulated expression in the pituitary gland. Our data suggest that the three footprinted sites within the promoter are functionally interchangeable and act in combination with promoter elements between -114 and -34. The inability of any reporter gene construction to dissociate basal and hormonally stimulated expression suggests that these DNA elements are involved in both of these two characteristics of POMC gene expression in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1508198      PMCID: PMC360283          DOI: 10.1128/mcb.12.9.3978-3990.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  40 in total

1.  An immunohistochemical study on the cytogenesis of adenohypophysial cells in fetal rats.

Authors:  Y G Watanabe; S Daikoku
Journal:  Dev Biol       Date:  1979-02       Impact factor: 3.582

2.  Affinity purification of sequence-specific DNA binding proteins.

Authors:  J T Kadonaga; R Tjian
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

Review 3.  Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues.

Authors:  A I Smith; J W Funder
Journal:  Endocr Rev       Date:  1988-02       Impact factor: 19.871

4.  Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40.

Authors:  W Lee; A Haslinger; M Karin; R Tjian
Journal:  Nature       Date:  1987 Jan 22-28       Impact factor: 49.962

5.  Function of the homeodomain protein GHF1 in pituitary cell proliferation.

Authors:  J L Castrillo; L E Theill; M Karin
Journal:  Science       Date:  1991-07-12       Impact factor: 47.728

6.  Nucleoprotein complexes that regulate gene expression in adipocyte differentiation: direct participation of c-fos.

Authors:  R J Distel; H S Ro; B S Rosen; D L Groves; B M Spiegelman
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

7.  Detection and quantitation of pro-opiomelanocortin mRNA in pituitary and brain tissues from different species.

Authors:  O Civelli; N Birnberg; E Herbert
Journal:  J Biol Chem       Date:  1982-06-25       Impact factor: 5.157

8.  Gonadotrope-specific expression of the human follicle-stimulating hormone beta-subunit gene in pituitaries of transgenic mice.

Authors:  T R Kumar; V Fairchild-Huntress; M J Low
Journal:  Mol Endocrinol       Date:  1992-01

9.  TEF, a transcription factor expressed specifically in the anterior pituitary during embryogenesis, defines a new class of leucine zipper proteins.

Authors:  D W Drolet; K M Scully; D M Simmons; M Wegner; K T Chu; L W Swanson; M G Rosenfeld
Journal:  Genes Dev       Date:  1991-10       Impact factor: 11.361

10.  Mechanisms of action of corticotropin-releasing factor and other regulators of corticotropin release in rat pituitary cells.

Authors:  G Aguilera; J P Harwood; J X Wilson; J Morell; J H Brown; K J Catt
Journal:  J Biol Chem       Date:  1983-07-10       Impact factor: 5.157

View more
  17 in total

1.  A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease.

Authors:  Mathias Riebold; Christian Kozany; Lee Freiburger; Michael Sattler; Michael Buchfelder; Felix Hausch; Günter K Stalla; Marcelo Paez-Pereda
Journal:  Nat Med       Date:  2015-02-09       Impact factor: 53.440

2.  Identification of neuronal enhancers of the proopiomelanocortin gene by transgenic mouse analysis and phylogenetic footprinting.

Authors:  Flávio S J de Souza; Andrea M Santangelo; Viviana Bumaschny; María Elena Avale; James L Smart; Malcolm J Low; Marcelo Rubinstein
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

3.  Brn-3.0: a POU-domain protein expressed in the sensory, immune, and endocrine systems that functions on elements distinct from known octamer motifs.

Authors:  M R Gerrero; R J McEvilly; E Turner; C R Lin; S O'Connell; K J Jenne; M V Hobbs; M G Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

4.  Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland.

Authors:  Eros Lazzerini Denchi; Claire Attwooll; Diego Pasini; Kristian Helin
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

5.  Authentic cell-specific and developmentally regulated expression of pro-opiomelanocortin genomic fragments in hypothalamic and hindbrain neurons of transgenic mice.

Authors:  J I Young; V Otero; M G Cerdán; T L Falzone; E C Chan; M J Low; M Rubinstein
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

6.  Enhancer turnover and conserved regulatory function in vertebrate evolution.

Authors:  Sabina Domené; Viviana F Bumaschny; Flávio S J de Souza; Lucía F Franchini; Sofía Nasif; Malcolm J Low; Marcelo Rubinstein
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-11-11       Impact factor: 6.237

7.  Retinoic acid prevents experimental Cushing syndrome.

Authors:  M Páez-Pereda; D Kovalovsky; U Hopfner; M Theodoropoulou; U Pagotto; E Uhl; M Losa; J Stalla; Y Grübler; C Missale; E Arzt; G K Stalla
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

8.  Developmental dependence on NurRE and EboxNeuro for expression of pituitary proopiomelanocortin.

Authors:  Pierre-Luc Lavoie; Lionel Budry; Aurélio Balsalobre; Jacques Drouin
Journal:  Mol Endocrinol       Date:  2008-04-03

9.  Functional redundancy of the DE-1 and alpha A-CRYBP1 regulatory sites of the mouse alpha A-crystallin promoter.

Authors:  C M Sax; J G Ilagan; J Piatigorsky
Journal:  Nucleic Acids Res       Date:  1993-06-11       Impact factor: 16.971

10.  Nasal administration of osteopontin peptide mimetics confers neuroprotection in stroke.

Authors:  Kristian P Doyle; Tao Yang; Nikola S Lessov; Thomas M Ciesielski; Susan L Stevens; Roger P Simon; Jeffrey S King; Mary P Stenzel-Poore
Journal:  J Cereb Blood Flow Metab       Date:  2008-03-26       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.